average weight loss on tirzepatide in first 3 months A real-world study of for adults without diabetes mellitus Tirzepatide after intensive lifestyle intervention

This dual mechanism is the primary pharmacological distinction between the two medications

Simple calculations help maintain consistent concentration for research applications

Epub 2020 Nov 18

Healthcare professionals should educate patients on these dangers and discourage them from purchasing or using compounded semaglutide

In this population of adults with overweight or obesity, use of tirzepatide was associated with significantly greater weight loss than semaglutide. Last week researchers reported significant but tentative findings that patients taking semaglutide were four times more likely to be diagnosed with an eye condition known as non-arteritic anterior ischemic optic neuropathy (naion)